(c) 2024 PillSync.com

gabapentin 300 mg

1 INDICATIONS AND USAGE Gabapentin is indicated for: • Management of postherpetic neuralgia in adults • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: • Postherpetic neuralgia in adults (1) • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

granules india limited


4 weeks ago CAPSULE YELLOW G57 gabapentin 300 mg

CAPSULE YELLOW G57

4 weeks ago CAPSULE YELLOW G57 gabapentin 300 mg

G57 CAPSULE YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING capsules

GABAPENTIN capsules, USP 100 mg are available for oral administration as hard gelatin capsules with a white opaque body, white opaque cap, hard gelatine capsule, imprinted G 56 black ink; supplied in bottles of 100 (NDC 62207-922-43), bottles of 500 (NDC 62207-922-47), bottles of 1000 (NDC 62207-922-49).

GABAPENTIN capsules, USP 300 mg are available for oral administration as hard gelatin capsules with a white opaque body, yellow opaque cap, hard gelatine capsules, imprinted G 57 black ink; supplied in bottles of 100 (NDC 62207-923-43), bottles of 500 (NDC 62207-923-47), bottles of 1000 (NDC 62207-923-49).

GABAPENTIN capsules, USP 400 mg are available for oral administration as hard gelatin capsules with a white opaque body, orange opaque cap, hard gelatine capsules, imprinted G 58 black ink; supplied in bottles of 100 (NDC 62207-924-43), bottles of 500 (NDC 62207-924-47). * Maalox ® is a registered trademark of Novartis Consumer Health Inc. Storage Store

GABAPENTIN at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light resistant container [see USP].


More pills like CAPSULE G57

Related Pills

gabapentin 300 mg

granules india limited

pregabalin 75 mg

Cipla USA, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site